TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.

Nancy U Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.